+43.2%
CVS vs SN
+476.8%
-433.6%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -3.3% | +2.6% | -0.6% |
| 7D | -1.9% | -3.4% | +1.5% | -1.8% |
| 30D | -0.3% | -9.1% | +8.8% | 0.0% |
| 3M | -1.1% | +31.8% | -32.9% | -2.7% |
| 6M | +23.7% | +52.0% | -28.3% | +20.4% |
| YTD | +23.0% | +51.3% | -28.3% | +19.6% |
| 1Y | +37.2% | +46.9% | -9.7% | +33.4% |
| 3Y | +62.4% | +394.9% | -332.5% | +35.5% |
| All | +43.2% | +476.8% | -433.6% | +20.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling